Instruction for use: Imovax D.T. Adult

Dosage form: Suspension for injections

Active substance: Vaccinum ad prophylaxim diphtheriae et tetani

ATX

J07AM51 Tetanus toxoid in combination with diphtheria toxoid

Pharmacological group:

Vaccines, serums, phages and toxoids

The nosological classification (ICD-10)

A35 Other forms of tetanus: Tetanus local; Tetanus; Muscle spasms in tetanus; Clostridiosis wound; Tetanus; Hydrophobia (hydrophobia)

A36.9 Diphtheria, unspecified

Composition and release form

1 dose of vaccine (0.5 ml of suspension for injection) contains 1 dose for revaccination of purified diphtheria toxoid and 1 dose for revaccination of purified tetanus toxoid.

1 dose of diphtheria toxoid (representing a dose reduced compared to vaccine) corresponds to at least 2 IU.

1 dose of tetanus toxoid corresponds to at least 20 IU (when measuring the protective activity of the vaccine in comparison with the international WHO standard or with other standards corresponding to the international standard).

Sorbent - aluminum hydroxide (in terms of aluminum - a maximum of 1.25 mg), preservative - thiomersal (maximum - 0.05 mg).

Suspension for injection is issued:

In vials of 10 or 20 doses; In a box of 10 bottles;

In ampoules and syringes for 1 dose; In the box 1 syringe or 1 ampoule.

Characteristic

Vaccine for the prevention of diphtheria and tetanus in children older than 6 years and adults. The vaccine is prepared from purified diphtheria and tetanus anatoxins, formalin-inactivated and adsorbed on aluminum hydroxide.

Pharmachologic effect

Mode of action - Immunostimulating.

Formation of specific immunity against diphtheria and tetanus toxins.

Clinical Pharmacology

Immunity develops after the second injection and persists for at least 5 years after the first revaccination.

Indication of the drug Imovax D.T.Adult

Vaccination and revaccination for the prevention of diphtheria and tetanus in adolescents and adults (especially those who have contraindications to the introduction of vaccines DT Vax, Tetrakok).

Contraindications

Hypersensitivity to the constituent components of the vaccine, acute infectious diseases, a pronounced reaction to the previous administration of the vaccine.

Side effects

Local reactions (soreness (rarely), densification and redness at the injection site). General reactions (slight increase in body temperature within 24-48 h after injection).

Dosing and Administration

SC or IM. Vaccination - 3 injections of 0.5 ml at intervals of 1 month, then revaccination (0.5 ml) - after 1 year and - every 5-10 years. Before use, the vial is shaken thoroughly until a homogeneous suspension is obtained.

Storage conditions of the drug Imovax D.T.Adult

At a temperature of 2-8 ° C.

Keep out of the reach of children.

Shelf life of the drug Imovax D.T.Adult

3 years.

Do not use after the expiry date printed on the package.